1. Home
  2. LXRX vs FBYDP Comparison

LXRX vs FBYDP Comparison

Compare LXRX & FBYDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LXRX

Lexicon Pharmaceuticals Inc.

HOLD

Current Price

$1.47

Market Cap

996.7M

Sector

Health Care

ML Signal

HOLD

FBYDP

Falcon's Beyond Global Inc. 11% Series B Cumulative Convertible Preferred Stock

N/A

Current Price

$8.00

Market Cap

1.1B

ML Signal

N/A

Company Overview

Basic Information
Metric
LXRX
FBYDP
Founded
1995
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
996.7M
1.1B
IPO Year
2000
2023

Fundamental Metrics

Financial Performance
Metric
LXRX
FBYDP
Price
$1.47
$8.00
Analyst Decision
Buy
Analyst Count
6
0
Target Price
★ $4.47
N/A
AVG Volume (30 Days)
★ 1.9M
2.8K
Earning Date
11-09-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 77.78
N/A
EPS
N/A
★ 0.04
Revenue
★ $49,803,000.00
$14,896,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$200.00
Revenue Growth
60.24
★ 120.85
52 Week Low
$1.10
$6.60
52 Week High
$2.68
$9.71

Technical Indicators

Market Signals
Indicator
LXRX
FBYDP
Relative Strength Index (RSI) 31.31 40.59
Support Level $1.10 $6.60
Resistance Level $1.81 $9.71
Average True Range (ATR) 0.08 0.62
MACD 0.00 -0.09
Stochastic Oscillator 24.69 45.02

Price Performance

Historical Comparison
LXRX
FBYDP

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: